格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-19-024663 Act: 34 Size: 47 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-19-024665 Act: 34 Size: 367 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-19-024255 Act: 34 Size: 221 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-19-024156 Act: 34 Size: 39 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-19-023789 Act: 34 Size: 44 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-30 AccNo: 0001213900-19-021434 Size: 141 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-25 AccNo: 0001213900-19-021106 Size: 507 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-24 AccNo: 0001213900-19-018726 Size: 31 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-09 AccNo: 0001213900-19-017448 Size: 33 KB 网页链接
$Alterity医疗(ATHE)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-09-03 AccNo: 0001213900-19-017068 Size: 40 KB 网页链接